X0508 4 2026-02-12 0 0001840877 Envoy Medical, Inc. COCH 0001213971 TAYLOR GLEN A C/O TAYLOR CORP, 1725 ROE CREST DR N MANKALO MN 56002 0 0 1 0 0 Class A Common Stock 2526058 I By Taylor Sports Group Class A Common Stock 4810384 I By GAT Funding, LLC Class A Common Stock 2026-02-12 4 P 0 18750000 0.40 A 21703607 D Warrant Shares (Series A-1) 0.40 2026-02-12 4 P 0 11250000 0 A Class A Common Stock 11250000 11250000 D Warrant Shares (Series A-2) 0.40 2026-02-12 4 P 0 18750000 0 A Class A Common Stock 18750000 18750000 D The Reporting Person is the owner and chairman of Taylor Sports Group. GAT Funding, LLC is an entity controlled by Reporting Person. The Series A-1 Warrants and Series A-2 Warrants (the "Common Warrants") will be exercisable beginning on the effective date of stockholder approval of the issuance of the shares upon exercise of the Common Warrants (the "Stockholder Approval Date"). The Series A-1 Warrants expire on the earlier of (i) the twenty-four month anniversary of the Stockholder Approval Date and (ii) thirty days following the date the Company publicly announces that it has submitted a Premarket Approval Application (PMA) to the U.S. Food and Drug Administration for its Acclaim cochlear implant (the "Series A-1 Milestone Event"). The Series A-2 Warrants expire on the earlier of (i) the sixty-month anniversary of the Stockholder Approval Date and (ii) thirty days following the date the Company publicly announces that it has received U.S. Food and Drug Administration approval for its Acclaim cochlear implant (the "Series A-2 Milestone Event"). /s/ Glen A. Taylor 2026-02-16